• 1
    Gaynes R., Edwards J.R. (2005) Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis;41:848854.
  • 2
    Stover C.K., Pham X.Q., Erwin A.L., Mizoguchi S.D., Warrener P., Hickey M.J., Brinkman F.S. et al. (2000) Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature;406:959964.
  • 3
    Craig L., Pique M.E., Tainer J.A. (2004) Type IV pilus structure and bacterial pathogenicity. Nat Rev Microbiol;2:363378.
  • 4
    Paranchych W., Frost L.S. (1988) The physiology and biochemistry of pili. Adv Microb Physiol;29:53113.
  • 5
    Mattick J. (2002) Type IV pili and twitching motility. Annu Rev Microbiol;56:289314.
  • 6
    Irvin R.T., Doig P.C., Sastry P.A., Heller B., Paranchych W. (1990) Usefulness of equilibrium parameters of adhesion in predicting the outcome of competition for bacterial receptor sites on respiratory epithelial cells by Pseudomonas aeruginosa strains of heterologous pilus type. Microb Ecol Health Dis;3:3947.
  • 7
    Lee K.K., Sheth H.B., Wong W.Y., Sherburne R., Paranchych W., Hodges R.S., Lingwood C.A., Krivan H., Irvin R.T. (1994) The binding of Pseudomonas aeruginosa pili to glycosphingolipids is a tip-associated event involving the C-terminal region of the structural pilin subunit. Mol Microbiol;11:705713.
  • 8
    Baker N.R. (1993) Mucosal adherence of Pseudomonas aeruginosa. In: Fick R.B. Jr, editor. Pseudomonas aeruginosa the Opportunist: Pathogenesis and Disease. Florida: CRC Press, Inc.; p. 723.
  • 9
    Chi E., Mehl T., Nunn D., Lory S. (1991) Interaction of Pseudomonas aeruginosa with A549 pneumocyte cells. Infect Immun;59:822828.
  • 10
    Farinha M.A., Conway B.D., Glasier L.M., Ellert N.W., Irvin R.T., Sherburne R., Paranchych W. (1994) Alteration of the pilin adhesin of Pseudomonas aeruginosa PAO results in normal pilus biogenesis but a loss of adherence to human pneumocyte cells and decreased virulence in mice. Infect Immun;62:41184123.
  • 11
    Tang H., Kays M., Prince A. (1995) Role of Pseudomonas aeruginosa pili in acute pulmonary infection. Infect Immun;63:12781285.
  • 12
    Hazes B., Sastry P.A., Hayakawa K., Read R.J., Irvin R.T. (2000) Crystal structure of Pseudomonas aeruginosa PAK pilin suggests a main-chain-dominated mode of receptor binding. J Mol Biol;299:10051017.
  • 13
    Keizer D.W., Kalisiak M., Crump M.P., Suh J.Y., Irvin R.T., Sykes B.D. (2001) Assignments of 1H and 15N resonances of the Pseudomonas aeruginosa K122- 4 pilin monomer. J Biomol NMR;19:385396.
  • 14
    Suh J.Y., Spyracopoulos L., Keizer D.W., Irvin R.T., Sykes B.D. (2001) Backbone dynamics of receptor binding and antigenic regions of a Pseudomonas aeruginosa pilin monomer. Biochemistry;40:39853995.
  • 15
    Craig L., Taylor R.K., Pique M.E., Adair B.D., Arvai A.S., Singh M., Lloyd S.J., Shin D.S., Getzoff E.D., Yeager M., Forest K.T., Tainer J.A. (2003) Type IV Pilin Structure and Assembly. X-Ray and EM Analyses of Vibrio cholerae Toxin-Coregulated Pilus and Pseudomonas aeruginosa PAK Pilin. Mol Cell;11:11391150.
  • 16
    Audette G.F., Irvin R.T., Hazes B. (2004) Crystallographic analysis of the Pseudomonas aeruginosa strain K122-4 monomeric pilin reveals a conserved receptor-binding architecture. Biochemistry;43:1142711435.
  • 17
    Lee K.K., Wong W.Y., Sheth H.B., Hodges R.S., Paranchych W., Irvin R.T. (1995) Use of synthetic peptides in characterization of microbial adhesins. Methods Enzymol;253:115131.
  • 18
    Campbell A.P., McInnes C., Hodges R.S., Sykes B.D. (1995) Comparison of NMR solution structures of the receptor binding domains of Pseudomonas aeruginosa pili strains PAO, KB7, and PAK: implications for receptor binding and synthetic vaccine design. Biochemistry;34:1625516268.
  • 19
    McInnes C., Sonnichsen F.D., Kay C.M., Hodges R.S., Sykes B.D. (1993) NMR solution structure and flexibility of a peptide antigen representing the receptor binding domain of Pseudomonas aeruginosa. Biochemistry;32:1343213440.
  • 20
    Keizer D.W., Slupsky C.M., Kalisiak M., Campbell A.P., Crump M.P., Sastry P.A., Hazes B., Irvin R.T., Sykes B.D. (2001) Structure of a pilin monomer from Pseudomonas aeruginosa: implications for the assembly of pili. J Biol Chem;276:2418624193.
  • 21
    Cachia P.J., Hodges R.S. (2003) Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa. Biopolymers;71:141168.
  • 22
    Cachia P.J., Glasier L.M., Hodgins R.R., Wong W.Y., Irvin R.T., Hodges R.S. (1998) The use of synthetic peptides in the design of a consensus sequence vaccine for Pseudomonas aeruginosa. J Pept Res;52:289299.
  • 23
    Kao D.J., Churchill M.E., Irvin R.T., Hodges R.S. (2007) Animal protection and structural studies of a consensus sequence vaccine targeting the receptor binding domain of the Type IV pilus of Pseudomonas aeruginosa. J Mol Biol;374:426442.
  • 24
    Erickson B.W., Merrifield R.B. (1976) Solid-phase peptide synthesis. In: NeurathH., HillR.L., editors. The Proteins. New York, USA: Academic Press; p. 255527.
  • 25
    Lee K.K., James A.B., Hodges R.S. (1991) Separation of intrachain disulfide bridged peptides from their reduced forms by reversed-phase chromotography. In: MantC.T., HodgesR.S., editors. HPLC of Peptides and Proteins: Separation, Analysis, and Conformation. Boca Raton: CRC Press; p. 389398.
  • 26
    Wetzel R., Halualani R., Stults J.T., Quan C. (1990) A general method for highly selective cross-linking of unprotected polypeptides via pH-controlled modification of N-terminal alpha-amino groups. Bioconjug Chem;1:114122.
  • 27
    Wong W.Y., Irvin R.T., Paranchych W., Hodges R.S. (1992) Antigen–antibody interactions: elucidation of the epitope and strain-specificity of a monoclonal antibody directed against the pilin protein adherence binding domain of Pseudomonas aeruginosa strain K. Protein Sci;1:13081318.
  • 28
    Hodges R.S., Heaton R.J., Parker J.M.R., Molday L., Molday R.S. (1988) Antigen–antibody interaction: synthetic peptides define linear antigenic determinants recognized by monoclonal antibodies directed to the cytoplasmic carboxyl terminus of rhodopsin. J Biol Chem;263:1176811775.